Read on Twitter
Moderna says preliminary trial data shows its coronavirus vaccine is more than 94% effective, shares soar. https://www.cnbc.com/amp/2020/11/16/moderna-says-its-coronavirus-vaccine-is-more-than-94percent-effective.html?__twitter_impression=true
Moderna said it's vaccine remains stable at 36 to 46 degrees Fahrenheit, the temperature of a standard home or medical refrigerator, for up to 30 days. It can be stored for up to six months at negative 4 degrees Fahrenheit.
Moderna said it was "actively preparing" for the global launch of its potential vaccine after completing enrollment in its trial a week earlier.
37% of the participants were from minority communities & 42% had other conditions or ages that put them at high risk of severe disease
37% of the participants were from minority communities & 42% had other conditions or ages that put them at high risk of severe disease
Males outnumber females in the trial by 53% to 47%.
Out of the 95 Covid-19 cases, 20 participants identified as being from "diverse" communities, including 12 Hispanic people, four African Americans, three Asian Americans and one multiracial.
Out of the 95 Covid-19 cases, 20 participants identified as being from "diverse" communities, including 12 Hispanic people, four African Americans, three Asian Americans and one multiracial.
In August, Moderna said it was charging between $32 and $37 per dose for its vaccine for some customers, under cheaper "pandemic pricing." The company said it was in discussion for larger volume agreements that will have a lower price.
